BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26173559)

  • 1. Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands.
    Duijmelinck DM; van de Ven WP
    Health Econ Policy Law; 2016 Apr; 11(2):141-59. PubMed ID: 26173559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.
    Keegan C; Teljeur C; Turner B; Thomas S
    Eur J Health Econ; 2016 Sep; 17(7):823-31. PubMed ID: 26359243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do people not switch insurer in a market-based health insurance market? Empirical evidence from the Netherlands.
    van der Schors W; Brabers AEM; de Jong JD
    Eur J Public Health; 2020 Aug; 30(4):633-638. PubMed ID: 32236545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of supplementary health insurance on switching behaviour: evidence from Swiss data.
    Dormont B; Geoffard PY; Lamiraud K
    Health Econ; 2009 Nov; 18(11):1339-56. PubMed ID: 19267356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled.
    de Jong JD; van den Brink-Muinen A; Groenewegen PP
    BMC Health Serv Res; 2008 Mar; 8():58. PubMed ID: 18366678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching health insurers: the role of price, quality and consumer information search.
    Boonen LH; Laske-Aldershof T; Schut FT
    Eur J Health Econ; 2016 Apr; 17(3):339-53. PubMed ID: 25820635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer mobility in social health insurance markets : a five-country comparison.
    Laske-Aldershof T; Schut E; Beck K; Gress S; Shmueli A; Van de Voorde C
    Appl Health Econ Health Policy; 2004; 3(4):229-41. PubMed ID: 15901197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of insurer for basic health insurance restricted by supplementary insurance.
    Duijmelinck DM; van de Ven WP
    Eur J Health Econ; 2014 Sep; 15(7):737-46. PubMed ID: 23887827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the chronically ill population in the Netherlands switch their health insurer as often as the general population? Empirical evidence from a nationwide survey study.
    van der Schors W; Brabers AEM; De Jong JD
    BMC Health Serv Res; 2020 May; 20(1):376. PubMed ID: 32370798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What health plans do people prefer? The trade-off between premium and provider choice.
    Determann D; Lambooij MS; de Bekker-Grob EW; Hayen AP; Varkevisser M; Schut FT; Wit GA
    Soc Sci Med; 2016 Sep; 165():10-18. PubMed ID: 27485728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intention to switch health insurer and actual switching behaviour: are there differences between groups of people?
    Hendriks M; de Jong JD; van den Brink-Muinen A; Groenewegen PP
    Health Expect; 2010 Jun; 13(2):195-207. PubMed ID: 19906212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching benefits and costs in the Irish health insurance market: an analysis of consumer surveys.
    Keegan C; Teljeur C; Turner B; Thomas S
    Int J Health Econ Manag; 2019 Mar; 19(1):15-32. PubMed ID: 29748937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching health insurance plans: results from a health survey.
    Lako CJ; Rosenau P; Daw C
    Health Care Anal; 2011 Dec; 19(4):312-28. PubMed ID: 20640891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences and choices for care and health insurance.
    van den Berg B; Van Dommelen P; Stam P; Laske-Aldershof T; Buchmueller T; Schut FT
    Soc Sci Med; 2008 Jun; 66(12):2448-59. PubMed ID: 18400349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
    Douven RC; Schut FT
    J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.